Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VIG vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VIG returned +13.9% to XBI's +41.2%, and VIG charges 0.04% to XBI's 0.35%.

askIQ about this page

askIQ about VIG and XBI

Net assets: $109.1bn on Sep 30, 2026 for Vanguard Div Appreciation ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+13.9%
VIG total return, 1 year
+41.2%
XBI total return, 1 year
0.04%
VIG expense ratio
0.35%
XBI expense ratio

Pair scorecard

VIG costs 0.31 points a year less; their one-year returns differ by 27.3 points; VIG is 10.5 times larger.

VIG vs XBI: Differences, Returns & Fees
MeasureVIGXBI
Return
Total return, 1 year+13.9%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksS&P U.S. Dividend Growers IndexBiotech
Cost and size
Expense ratio0.04%0.35%
Net assets, as of Sep 30, 2026$109.1bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common3%
Top ten holdings, share of the fund34.5%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

3%

By the books each fund has filed, VIG and XBI hold 3% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first VIG XBI
AbbVie Inc 2.05% 1.67%
Amgen Inc 1.01% 1.68%
Gilead Sciences Inc 0.82% 1.60%
Only in one fund ↓
Only in VIG
Microsoft Corp 4.90%
Apple Inc 4.88%
Broadcom Inc 4.30%
Eli Lilly & Co 4.10%
JPMorgan Chase & Co 3.89%
ExxonMobil Holdings Corp 2.96%
Johnson & Johnson 2.83%
Visa Inc 2.53%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
SPYRE THERAPEUTICS INC 1.67%
EXELIXIS INC 1.64%
Check overlap with more funds →

Side by side

VIG Vanguard Div Appreciation ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of Dividend growth Biotech
Total return, 1 year +13.9% +41.2%
Expense ratio 0.04% 0.35%
Already in the S&P 500 92.6% 13.2%
Holdings 335 165
Net assets, VIG as of Sep 30, 2026 and XBI as of Oct 27, 2026 $109.1bn $10.3bn

VIG and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VIG

VIG tracks an index of Dividend growth. Over the year to Oct 28, 2026 it returned +13.9% with distributions reinvested. The prospectus expense ratio is 0.04% a year. By its holdings published by its issuer as of Sep 30, 2026, 93% of the fund by weight is stocks the S&P 500 also holds, across 335 positions, with the top ten at 34.5%.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VIG and XBI in the same category?
VIG is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VIG or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VIG returned +13.9% and XBI +41.2%.
Which is cheaper, VIG or XBI?
VIG is cheaper, by 0.31 percentage points a year. That is about $31 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do VIG and XBI overlap with the S&P 500?
By their latest filed holdings, 93% of VIG and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VIG against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vig-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.